Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies TacticGem LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chandler Robinson - $2.56M in MNPR purchases and sales in the last 12 months
- Kim R. Tsuchimoto - $911K in MNPR purchases and sales in the last 12 months
- Raymond Anderson - $703K in MNPR purchases and sales in the last 12 months
- Christopher M. Starr - $659K in MNPR purchases and sales in the last 12 months
- Patrice Rioux - $111 in MNPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is TacticGem LLC?
TacticGem LLC is a corporate entity, tracked as 10% Owner of Monopar Therapeutics (MNPR). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did TacticGem LLC last file a Form 4?
The only primary Form 4 on record is dated 17 December 2024.
